Rising Demand For Renal Biomarkers Impact Of Geriatric And Pediatric Patients: A Significant Driver Propelling The Renal Biomarkers Market In 2025

The Renal Biomarkers Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Renal Biomarkers Market Size and Projected Growth Rate?
The market size for renal biomarkers has experienced robust growth in the past few years. The market, which was valued at $1.28 billion in 2024, is projected to increase to $1.38 billion in 2025, representing a compound annual growth rate (CAGR) of 7.8%. Factors like the rising prevalence of kidney ailments, advancements in medical diagnostic technology, an aging demographic, enhanced consciousness about early disease detection, the adoption of point-of-care testing, and an increase in chronic diseases have all contributed to its growth during the historical period.

The market for renal biomarkers is predicted to experience robust expansion in the upcoming years, escalating to a value of $1.91 billion by 2029, with an 8.5% compound annual growth rate (CAGR). This growth projection for the period is attributed to factors such as the implementation of personalized medicine and targeted therapies, incorporation of biomarker testing in regular clinical practices, burgeoning markets in Asia and Latin America, non-invasive methods of biomarker testing, and consistent monitoring through wearable technology. Key trends for the forecast period encompass multiplex biomarker panels for all-inclusive disease profiling, the utilization of AI and machine learning for biomarker identification, companion diagnostics based on biomarkers, point-of-care biomarker examination in home healthcare surroundings, and biomarkers meant for early detection and prevention.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7711

What Are the Major Segments in the Renal Biomarkers Market?
The renal biomarkers market covered in this report is segmented -

1) By Biomarker Type: Functional Biomarker, Up Regulated Protein, Other Biomarker Types
2) By Diagnostic Technique: Enzyme-Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LS-MS)
3) By Application: Diagnosis And Disease Progression Monitoring, Research Homecare
4) By End User: Hospitals, Diagnostic Laboratories, Other End Users

Subsegments:
1) By Functional Biomarker: Creatinine, Urea, Cystatin C, Bicarbonate
2) By Up Regulated Protein: Neutrophil Gelatinase-Associated Lipocalin (NGAL), Kidney Injury Molecule-1 (KIM-1), Interleukin-18 (IL-18)
3) By Other Biomarker Types: Proximal Tubule Injury Biomarkers, Acute Kidney Injury Biomarkers, Chronic Kidney Disease Biomarkers

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7711&type=smp

What Are The Driving Renal Biomarkers Market Evolution?
Elevated numbers of elderly and young patients with kidney issues are anticipated to stimulate the renal biomarkers market's expansion in the future. Elderly patients with severe chronic kidney disease (CKD), commonly known as geriatric renal patients, are typically above the age of 70. On the other hand, paediatric renal patients are usually diagnosed with kidney disorders during their childhood and young adult years. Renal biomarkers are pivotal in determining the intensity of kidney injury in both elderly and young patients. For instance, the Australian Institute of Health and Welfare, a government body based in Australia, reported in June 2024 that chronic kidney disease (CKD) mortality rates had seen a rise by 4.2% in 2021 and 6.2% in 2022. This upward trend in both geriatric and pediatric renal patents, thus, fuels the expansion of the renal biomarkers market.

Which Firms Dominate The Renal Biomarkers Market Segments?
Major companies operating in the renal biomarkers market include Abbott Laboratories, BioPorto Diagnostics A/S, Roche Holding AG, Thermo Fisher Scientific, bioMérieux SA, Randox Laboratories, Siemens Healthineers, Beckman Coulter Inc., Astute Medical Inc., Nexelis Company, Sphingotec GmbH, Bio-Rad Laboratories India Pvt. Ltd., Enzo Biochem Inc., PerkinElmer Inc., Novartis AG, Alere Inc., AstraZeneca plc, Bio-Techne Corp., DiaSorin S.p.A., EKF Diagnostics Holdings plc, Fujirebio Diagnostics Inc., Gold Standard Diagnostics Corp., Merck KGaA, Myriad RBM Inc., Ortho Clinical Diagnostics Holdings plc, Quidel Corporation, R&D Systems Inc., Roche Diagnostics International Ltd ., Sekisui Chemical Co. Ltd., Sysmex Corporation, Tosoh Bioscience Inc.

What Trends Are Expected to Dominate the Renal Biomarkers Market in the Next 5 Years?
Innovation in technology is emerging as a prominent trend in the renal biomarkers arena. Major industry players are focusing on creating pioneering solutions to maintain their market standing. To illustrate, in March 2022, Nipro Medical Corporation, an American medical equipment manufacturer, introduced the SURDIAL DX. This groundbreaking hemodialysis system incorporates leading-edge technology dedicated to maximizing patient safety, well-being, and productivity. It consist of hi-tech design features like automated streamlined procedures, ergonomic configuration, and a pledge to improve the general dialysis treatment process.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report

Which Is The Largest Region In The Renal Biomarkers Market?
North America was the largest region in the renal biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region during the forecast period. The regions covered in the renal biomarkers market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Renal Biomarkers Market?
2. What is the CAGR expected in the Renal Biomarkers Market?
3. What Are the Key Innovations Transforming the Renal Biomarkers Industry?
4. Which Region Is Leading the Renal Biomarkers Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.